NextPlat (NASDAQ:NXPL) Shares Scheduled to Reverse Split on Monday, April 6th

Shares of NextPlat Corp. (NASDAQ:NXPL) are set to reverse split on the morning of Monday, April 6th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, April 5th.

NextPlat Stock Performance

Shares of NXPL opened at $0.39 on Thursday. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The stock has a market cap of $10.57 million, a P/E ratio of -0.89 and a beta of 1.38. The company has a 50-day moving average of $0.54 and a two-hundred day moving average of $0.65. NextPlat has a 12-month low of $0.34 and a 12-month high of $1.11.

NextPlat (NASDAQ:NXPL) last announced its quarterly earnings results on Tuesday, March 31st. The company reported ($0.24) earnings per share (EPS) for the quarter. The business had revenue of $12.81 million during the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of NextPlat in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Institutional Investors Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Simplicity Wealth LLC acquired a new stake in NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned 2.31% of NextPlat as of its most recent SEC filing. Institutional investors own 1.30% of the company’s stock.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.